arrow
J

Juan Tamargo

universidad complutense
H指数:84
被引数:10.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cardiovascular prescriber attitudes to pharmacogenomics: a survey by the ESC working group on cardiovascular pharmacotherapy

心血管处方者对药物基因组学的态度:欧洲心脏病学会心血管药物治疗工作组的一项调查

2026-04-230
OAAI
European Journal of Heart Failure consensus statement. Heart failure pharmacotherapy for patients with heart failure with reduced ejection fraction and concomitant atrial fibrillation: Review of evidence and call to action

《欧洲心力衰竭杂志》共识声明。射血分数降低的心力衰竭合并房颤患者的药物治疗:证据回顾与行动倡议

2025-10-220
OAAI
Antithrombotic therapy after coronary artery bypass graft surgery: a Clinical Consensus Statement of the ESC Working Group on Cardiovascular Surgery, the ESC Working Group on Cardiovascular Pharmacotherapy, and the European Association for Cardio-Thoracic Surgery (EACTS)

冠状动脉旁路移植术后抗血栓治疗:欧洲心脏病学会心血管外科工作组、欧洲心脏病学会心血管药物治疗工作组及欧洲心胸外科协会(EACTS)的临床共识声明

2025-08-300
PRE
Antithrombotic therapy after coronary artery bypass graft surgery: a Clinical Consensus Statement of the ESC Working Group on Cardiovascular Surgery, the ESC Working Group on Cardiovascular Pharmacotherapy, and the European Association for Cardio-Thoracic Surgery (EACTS)

冠状动脉旁路移植术后抗血栓治疗:欧洲心脏病学会心血管外科工作组、欧洲心脏病学会心血管药物治疗工作组及欧洲心胸外科协会(EACTS)的临床共识声明

2025-08-011
OAAI
Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology

抗心律失常药物实用汇编:欧洲心脏节律协会(ESC)的临床共识声明

2025-03-300
OA
Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects

聚焦2024年ESC/EACTS房颤管理指南:10大全新关键要点

2024-12-240
OAAI
Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on Thrombosis
2024-09-054
PRE